Haemonetics HAE Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $175.44M+4.3% | $168.19M+3.0% | $163.34M-2.6% | $167.68M+28.9% | ||
| $111.72M-0.8% | $112.61M-1.4% | $114.25M-0.8% | $115.21M-0.3% | $115.59M+0.5% | ||
| $33.83M+6.9% | $31.64M-1.3% | $32.05M+2.3% | $31.32M+5.7% | $29.64M-1.6% | ||
| $95.13M— | —— | —— | —— | —— | ||
| $714K-57.0% | $1.66M+3.6% | $1.6M-12.9% | $1.84M-88.3% | $15.7M+5.1% | ||
| $14.88M+184% | -$17.69M-264% | -$4.86M-91.2% | -$2.54M+63.4% | -$6.96M— | ||
| -$47.36M-22.9% | -$38.54M-423% | -$7.36M-129% | $25.18M-61.1% | $64.7M-22.7% | ||
| —— | —— | —— | —— | —— | ||
| $10.73M+62.1% | $6.62M-18.7% | $8.13M-17.6% | $9.87M-1.1% | $9.98M-28.7% | ||
| $293.22M-13.5% | $338.84M+17.2% | $289.04M+27.6% | $226.54M+24.7% | $181.73M+40.6% | ||
| $32.78M+6.6% | $30.76M-6.7% | $32.96M-11.8% | $37.38M-4.8% | $39.28M+29.5% | ||
| $60.18M— | —— | —— | —— | —— | ||
| $36.07M-9.1% | $39.67M+21.1% | $32.74M-5.6% | $34.69M+102% | $17.14M-9.6% | ||
| $1.38M-58.3% | $3.3M+5.8% | $3.12M-14.5% | $3.65M-84.3% | $23.25M+8.9% | ||
| -$179.55M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $0-100% | $6.25M0.0% | $6.25M+33.3% | $4.69M0.0% | $4.69M-29.2% | ||
| —— | —— | —— | —— | —— | ||
| $5M+0.9% | $4.96M-5.5% | $5.24M-0.6% | $5.27M-48.5% | $10.24M0.0% | ||
| -$102K+12.1% | -$116K+53.8% | -$251K-12.6% | -$223K+10.4% | -$249K+24.5% | ||
| $0— | —— | —— | —— | —— | ||
| -$180.49M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$64.85M— | —— | —— | —— | —— | ||
| $5.81M-31.2% | $8.45M-19.3% | $10.47M-13.9% | $12.15M-18.7% | $14.96M-4.5% | ||
| $95.13M— | —— | —— | —— | —— | ||
| -$1.88M+73.8% | -$7.16M+42.5% | -$12.45M+29.8% | -$17.74M+23.0% | -$23.02M-33.3% | ||
| $0— | —— | —— | —— | —— | ||
| —— | —— | —— | -$349K-54.4% | -$226K-104% | ||
| $36.07M-9.1% | $39.67M+21.1% | $32.74M-5.6% | $34.69M+102% | $17.14M-9.6% | ||
| $1.38M-58.3% | $3.3M+5.8% | $3.12M-14.5% | $3.65M-84.3% | $23.25M+8.9% | ||
| -$51.89M-1.6% | -$51.06M-17.4% | -$43.51M-53.4% | -$28.36M-34.3% | -$21.11M-34.9% | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $7.89M-0.8% | $7.96M-4.9% | $8.37M0.0% | $8.37M+0.4% | $8.33M+3.0% | ||
| $0-100% | $22.05M-50.0% | $44.1M-33.3% | $66.15M-25.0% | $88.2M+33.3% | ||
| $0— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$102K+12.1% | -$116K+53.8% | -$251K-12.6% | -$223K+10.4% | -$249K+24.5% | ||
| —— | —— | —— | —— | —— | ||
| $300M+10.5% | $271.38M+11.8% | $242.75M+13.4% | $214.13M+15.4% | $185.5M+33.3% | ||
| $0— | —— | —— | —— | —— | ||
| $0-100% | $62.5M-50.0% | $125M-33.3% | $187.5M-25.0% | $250M+33.3% | ||
| $47.26M+33.3% | $35.44M+50.0% | $23.63M+100% | $11.81M— | $0— | ||
| $35.81M+33.3% | $26.86M+50.0% | $17.91M+100% | $8.95M— | $0— | ||
| $260.44M-15.5% | $308.08M+20.3% | $256.08M+35.4% | $189.17M+32.8% | $142.45M+44.0% | ||
| $260.44M-15.5% | $308.08M+20.3% | $256.08M+35.4% | $189.17M+32.8% | $142.45M+44.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.